Bitter Pill: Merck To Cut 7,000 More Jobs Merck, one of the country's biggest pharmaceutical makers, announced Wednesday it is slashing more than 7,000 positions, or 12 percent of its global work force. Those cuts come on top of more than 10,000 jobs that were eliminated in an earlier restructuring.
NPR logo

Bitter Pill: Merck To Cut 7,000 More Jobs

  • Download
  • <iframe src="https://www.npr.org/player/embed/95970691/95967131" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Bitter Pill: Merck To Cut 7,000 More Jobs

Bitter Pill: Merck To Cut 7,000 More Jobs

  • Download
  • <iframe src="https://www.npr.org/player/embed/95970691/95967131" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

RENEE MONTAGNE, host:

NPR's business news starts with layoffs and more layoffs.

(Soundbite of music)

MONTAGNE: One of the country's biggest pharmaceutical makers, Merck, today said it's slashing more than 7,000 positions, or 12 percent, of its global workforce. The cuts were announced as the company reported a sharp drop in income for the recent quarter. It's partly due to fewer sales of Merck's cholesterol pills, Vytorin and Zetia. Merck also faces competition from generic drug makers as patents on top-selling medications expire. Rival drug company Pfizer faces the same problem. The maker of top-selling cholesterol drug Lipitor has already cut more than 14,000 jobs since last year, and workers there are bracing for more.

Copyright © 2008 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.